Happy Monday Cannabis Investors! No news yet from the DEA on rescheduling cannabis. But there was news that there could be news soon! And this not-quite-news was enough to send cannabis stocks jumping. It’s almost like investors are tired of sitting on the edge of their seats.

Also, check out the newest episode of Cannabis Insider, also available on Apple and Spotify.*

Puff Pass: Did someone forward you this email? Click here to get automatically subscribed.

TOP STORY

Do Meta And Other Platforms Play A Role In Illicit Drug Sales?

Briefly: Prosecutors in Virginia are probing whether Facebook and Instagram are facilitating and profiting from the illegal sale of drugs.

What Happened: Investigators seek to determine whether Meta failed to adequately remove drug-related content from its platforms.

Back Up: A surge of telehealth companies aggressively marketing prescription drugs on social media has raised industry-wide questions of how these platforms could be contributing to the misuse of controlled substances.

What Else: In a related move at the end of February, New York Governor Kathy Hochul and licensed dispensary owners accused major Meta and Alphabet of promoting unlicensed cannabis businesses.

Click here to see what this means for social media platforms.

WHERE DEALS GET DONE

The Benzinga Cannabis Capital Conference is where deals get done.

With 2,000+ decision-makers in one room, attendees have the chance to engage in a year's worth of networking in just two days. More than 100 CEOs and 200 Investors confirmed for Investment and Branding on April 16th - 18th at The Diplomat Beach Resort in Hollywood, FL.

Boris Jordan, executive chairman of Curaleaf, to deliver Keynote Speech.

Don't be the ONLY cannabis leader missing this event.

ZINGERS

Transatlantic Partnership: Döhler Ventures invests in Vertosa for cannabis-infused beverage innovation

Prime Harvest's forward-thinking strategy sparked a resurgence

VP Kamala Harris urges DEA to reschedule cannabis 'as quickly as possible,' calls prohibition 'absurd' and 'unfair'

High Tide, the second-largest cannabis retailer in North America, reports record revenue, adjusted EBITDA in Q1

Cannabis investment wave: Who's leading the charge?

ONE FOR THE ROAD

New York Gov Hochul Orders Review Of Cannabis Licensing Process After Numerous Setbacks

Briefly: New York's Office of Cannabis Management has been plagued with lawsuits and setbacks for the past two years.

So Basically: Governor Kathy Hochul ordered a review of the state’s cannabis licensing process, nearly two months after saying she was fed up with the slow rollout of the marijuana market.

So Then: Hochul asked officials to find a solution to the inefficient cannabis licensing scheme amid a growing number of illicit pot shops and widespread frustration over the sluggish roll-out.

So What? The New York Office of Cannabis Management obtained 7,000 applications last fall but has awarded only 109 this year, with 32 people in charge of evaluating applications. The OCM has been criticized and sued multiple times.

Click here to read more.

WHERE DEALS GET DONE

The Benzinga Cannabis Capital Conference is where deals get done.

With 2,000+ decision-makers in one room, attendees have the chance to engage in a year's worth of networking in just two days. More than 100 CEOs and 200 Investors confirmed for Investment and Branding on April 16th - 18th at The Diplomat Beach Resort in Hollywood, FL.

Boris Jordan, executive chairman of Curaleaf, to deliver Keynote Speech.

Don't be the ONLY cannabis leader missing this event.

KEEP READING

Before you go, be sure to subscribe to our other newsletters:

Ring The Bell: If you have to pick just one daily financial newsletter, it’s not a choice. Subscribe here.

The Street Sheet: A Wall Street cheat sheet, delivered every Sunday directly to your inbox. One-click subscribe here.

Future Finance: TradFi is tired. Wake up to the future of finance with this midday fintech and crypto letter. Subscribe here.

The Flag: Top takes from Washington to Wall Street impacting policy and your portfolio. One-click subscribe here.